- First Opinion Liquid biopsy research should include the perspectives of patients like me
- Health Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
- Biotech New results show benefits of Esperion’s cholesterol drug — but leave big questions unanswered
- First Opinion Landmark ruling sets precedent for parity coverage of mental health and addiction treatment
- First Opinion The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs
- Health Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate
- Don't Miss Vote now: Pick the best ideas in biomedical science
- Health An AIDS therapy involving parasite injections was discredited. China is reviving it — for cancer
-
- First Opinion Liquid biopsy research should include the perspectives of patients like me
- First Opinion Landmark ruling sets precedent for parity coverage of mental health and addiction treatment
